APA

Naud P. S., Roteli-Martins C. M., De Carvalho N. S., Teixeira J. C., de Borba P. C., Sanchez N., Zahaf T., Catteau G., Geeraerts B. & Descamps D. (20150727). Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination. : Human vaccines & immunotherapeutics.

Chicago

Naud Paulo S, Roteli-Martins Cecilia M, De Carvalho Newton S, Teixeira Julio C, de Borba Paola C, Sanchez Nervo, Zahaf Toufik, Catteau Gregory, Geeraerts Brecht and Descamps Dominique. 20150727. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination. : Human vaccines & immunotherapeutics.

Harvard

Naud P. S., Roteli-Martins C. M., De Carvalho N. S., Teixeira J. C., de Borba P. C., Sanchez N., Zahaf T., Catteau G., Geeraerts B. and Descamps D. (20150727). Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination. : Human vaccines & immunotherapeutics.

MLA

Naud Paulo S, Roteli-Martins Cecilia M, De Carvalho Newton S, Teixeira Julio C, de Borba Paola C, Sanchez Nervo, Zahaf Toufik, Catteau Gregory, Geeraerts Brecht and Descamps Dominique. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination. : Human vaccines & immunotherapeutics. 20150727.